Homer1a/Vesl-1S is an activity-dependently induced member of the scaffold protein family Homer/Vesl, which is known to link group I metabotropic glutamate receptors (mGluRs) to endoplasmic calcium release channels and to regulate them.
INTRODUCTION

Drugs used
Depending on the purpose of the experiments, D-2-amino-5-phosphonovaleric acid (D-APV, 50 µM; Tocris, Bristol, UK) or 2-methyl-6-(phenylethynyl)-pyridine (MPEP, 10 µM; Tocris) was bath-applied.
Homer 1a protein (1 or 3 µg/ml), anti-Homer 1a antibody (0.4 µg/ml), or heparin (1 mg/ml; Nacalai, Kyoto, Japan) was contained in the pipette solution and distributed into the cell by diffusion.
Data analysis
Electrophysiological data were filtered at 5 kHz and digitized at 10 kHz (Digidata 1322A and pClamp8, Axon Instruments). For data analysis, pClamp9
(Axon Instruments) was used for calculating the amplitude of EPSCs, and three samples were averaged for each data point. EPSC amplitudes were normalized to baseline and expressed as averages ± SEM. The magnitude of LTD was assessed by comparing the average amplitude of responses, obtained between 31-35 min after conditioning stimulation, with the pre-conditioning control. Paired or unpaired t-tests were used for statistics with the significance level set at p < 0.05.
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Group I mGluR-dependent LTD in layer VI pyramidal cells was suppressed by
Homer 1a injection
EPSCs were recorded from layer VI pyramidal cells bathed in normal medium with or without Homer 1a protein injected. The presynaptic stimulation electrode was placed between layer II and III. In agreement with the previous data (Rao and Daw 2004) , LTD was induced in control experiments without Homer 1a (61.1 ± 5.2 %, n = 7; Fig. 1A ). With Homer 1a injected by diffusion from patch pipettes (1 µg/ml), LTD magnitude at the late phase ( 22 min post-pairing) was significantly reduced (79.4 ± 6.1 %, n = 9; p < 0.03, 22 min post-pairing; Fig. 1B ). On the other hand, the baseline transmission was not changed even with Homer 1a injected (97.5 ± 12.6 %, n = 4). We have previously reported that injection of Homer 1a protein elicited hyperpolarization of rat visual cortex pyramidal cells in layer II/III under current clamp condition by using potassium-based internal solution. In that case, hyperpolarization was progressed gradually and reached the steady state within 10 min after break-in (Sakagami et al. 2005) , indicating that diffusion of Homer 1a must be completed within 10 min. We therefore started LTD induction at least 10 min after the whole-cell break-in in the present study.
LTD is often classified into mGluR-dependent and NMDAR-dependent ones (Oliet et al. 1997) . Recently, it has been reported that LTD induced by 1 Hz presynaptic simulation of layer II/III paired with postsynaptic depolarization to -40 mV in layer VI of the rat visual cortex was dependent on group I mGluRs, but not on NMDARs (Daw et al. 2004; Rao and Daw 2004) . This finding was first confirmed in the present experiments. With the NMDAR antagonist D-APV bath-applied (50 µM), LTD was still induced (70.8 ± 4.6 %, n = 6; Fig. 1C ). On the other hand, bath-application of MPEP (10 µM), a non-competitive group I mGluR (mGluR5)
antagonist, significantly suppressed LTD (83.8 ± 7.7 %, n = 7; p < 0.03; Fig. 1D ).
Both subtypes of group I mGluRs, mGluR1 and mGluR5, are involved in group I mGluR-dependent long-term synaptic plasticity (Wang and Daw 2003; Volk et al. 2006 ). However, in pyramidal cells of the rat neocortex, the expression of mGluR5 is much more prominent than that of mGluR1 (Shigemoto et al. 1993) . Furthermore, mGluR5 rather than mGluR1 seems to be preferentially associated with
Homer-mediated signaling in the rat visual cortex (Yamamoto et al. 2005) . We therefore used the mGluR5 antagonist MPEP as a representative group I mGluR antagonist. To check involvement of the IP3 signaling downstream of group I mGluRs, we examined the effect of IP3R blocker heparin on LTD in layer VI pyramidal cells. With heparin (1 mg/ml) injected by diffusion from patch pipettes, LTD was significantly suppressed (85.8 ± 6.8 %, n = 7; p < 0.02; Fig. 1E ). The dependence of layer VI LTD on the mGluR-IP3 signaling is consistent with its Homer 1a sensitivity, since Homer 1a is known to modulate the mGluR-IP3
signaling by agonist-independent activation of mGluR (Ango et al. 2001; Yamamoto et al. 2005) or its dominant-negative effect on constitutive Homers (Fagni et al. 2002) .
LTD was insensitive to Homer 1a in layer II/III and layer V pyramidal cells
EPSCs were recorded from layer II/III pyramidal cells with or without
Homer 1a injected. The presynaptic stimulation electrode was placed in layer IV.
Without Homer 1a, LTD was induced in normal medium (60.9 ± 5.0 %, n = 7; Fig.   2A ). In contrast to the findings obtained from layer VI neurons, Homer 1a injection allowed induction of a comparable LTD (1 µg/ml, 56.1 ± 3.6 %, n = 8; Fig. 2B ). LTD of much the same amplitude was observed again with the triple concentration of Homer 1a (3 µg/ml, 55.8 ± 4.2 %, n = 6; Fig. 2B ), suggesting that the lack of Homer 1a effect was not due to low concentration. In layer II/III, LTD was significantly suppressed with bath-application of D-APV (50 µM, 82.4 ± 5 %, n = 9; p < 0.01; Fig.   2C ). Bath-application of MPEP (10 µM), on the other hand, failed to block LTD (54.0 ± 5.1 %, n = 4; Fig. 2D ).
LTD was also induced in layer V pyramidal cells in normal medium (56.9 ± 5 %, n = 8; when Homer 1a concentration was increased three-fold (3 µg/ml, 65.6 ± 5.8 %, n = 4; Fig. 3B ). This layer V LTD was completely inhibited by applying D-APV (50 µM, 102
± 10 %, n = 5; p < 0.005; Fig. 3C ), whereas the group I mGluR antagonist MPEP (10 µM) allowed induction of significant LTD (59 ± 10.4 %, n = 5; Fig. 3D ).
ECS inhibited LTD in layer VI, but not in layer II/III or V pyramidal cells
The experiments so far suggest that Homer 1a could modulate mGluR-mediated LTD in layer VI. Although the mGluR antagonist MPEP or IP3R
blocker heparin strongly suppressed LTD immediately after the induction protocol, the suppressing effect of injected Homer 1a slowly emerged and was not apparent at the earliest phase of LTD. Because intracellular distribution of injected Homer 1a
protein was not visualized in our present study, we could not exclude the possibility that only a limited amount of Homer 1a was localized at synaptic sites at the earliest phase of LTD. To assure intracellular distribution of Homer 1a, we made use of ECS, a powerful experimental tool that has been confirmed to induce endogenous Homer 1a (Brakeman et al. 1997; Altar et al. 2004) . Previous studies showed that activity-induced endogenous Homer 1a protein was accumulated in postsynaptic region (Kato et al. 2001) . We thus examined whether ECS-induced Homer 1a, as well as Homer 1a injected from the pipette, alters neocortical LTD.
In slices obtained from ECS-subjected rats, LTD was significantly suppressed soon after pairing protocol in layer VI (90.2 ± 3.7 %, n = 9; p < 0.001, as compared with the no-ECS control; Fig. 4A ), although baseline transmission was not changed (86.5 ± 4.3 %, n = 4). ECS triggers expression of not only Homer 1a, but a large number of gene products, some of which are thought to be involved in long-term synaptic plasticity (Altar et al. 2004 ). Previously, we reported that Homer 1a induced by ECS hyperpolarizes rat visual cortex pyramidal cells and up-regulates L-type calcium channel currents under current-clamp mode with potassium-based internal solution, and that both of these two Homer 1a effects were disrupted by co-application of anti-Homer 1a antibody (Sakagami et al. 2005; Yamamoto et al. 2005) . We therefore checked the involvement of Homer 1a by using anti-Homer 1a antibody (0.4 µg/ml). In ECS-subjected tissue, the antibody injected through patch pipettes restored LTD (61.9 ± 8.3 %, n = 5, not statistically different from the no-ECS control; Fig. 4B ). However, rabbit IgG (0.4 µg/ml) injection failed to restore LTD (90.9 ± 9.5 %, n = 4, not statistically different from ECS just cases),
indicating that the effect of anti-Homer 1a antibody is not non-specific. It was thus
shown that the suppressing effect of ECS on LTD in layer VI was mediated at least partly by Homer 1a.
For a control purpose, we further carried out sub-ECS treatment, which is an electrical shock of a reduced intensity subthreshold to seizure. Sub-ECS was incapable of producing sufficient amounts of endogenous Homer 1a protein (our own unpublished observation), in agreement with the report that Homer 1a induction requires convulsion (Brakeman et al. 1997; Potschka et al. 2002) . In slices from the sub-ECS group, significant LTD was still induced in layer VI pyramidal cells (66.9 ± 4.3 %, n = 5, not statistically different from the no-ECS control; Fig. 4C ). However, in contrast to the findings obtained from ECS group, the earliest phase of LTD appeared to be reduced.
As shown above, LTD in layer II/III (Fig. 2B ) or layer V pyramidal cells ( 
